Skip to main content
BMC Cancer logoLink to BMC Cancer
. 2018 Jul 18;18:743. doi: 10.1186/s12885-018-4593-1

Correction to: the impact of pharmacokinetic gene profiles across human cancers

Michael T Zimmermann 1,2, Terry M Therneau 1, Jean-Pierre A Kocher 1,
PMCID: PMC6050650  PMID: 30021563

Correction to: BMC Cancer (2018) 18:577 DOI https://doi.org/10.1186/s12885-018-4345-2

It has been highlighted that in the original manuscript [1] Fig. 1 was omitted and Fig. 2 appeared twice. This Correction article shows the correct Fig. 1. The original article has been updated.

Fig. 1.

Fig. 1

Human tumors may up- or down-regulate PK genes. Each gene was scored relative to a composite-normal reference to generate conservative. Q6 f1:2 estimates of aberrant somatic gene expression. RSEM normalized gene expression data were used. The expression score of each gene in each tumor. f1:3 sample is the signed Z-score relative to normal tissue samples. Example probability density distributions of gene expression for two genes are shown: f1:4 (Left) drug importer SLC16A2 and (Right) drug exporter ABCC5

Footnotes

The original article can be found online at 10.1186/s12885-018-4345-2

Reference

  • 1.Zimmermann MT, et al. The impact of pharmacokinetic gene profiles across human cancers. BMC Cancer. 2018;18:577. doi: 10.1186/s12885-018-4345-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Cancer are provided here courtesy of BMC

RESOURCES